Low-intensity warfarin reduces thrombin generation and fibrin turnover, but not low-grade inflammation, in men at risk of myocardial infarction
- 20 October 2004
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 127 (4) , 448-450
- https://doi.org/10.1111/j.1365-2141.2004.05222.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart DiseaseNew England Journal of Medicine, 2004
- Anticoagulation with warfarin downregulates inflammationJournal of Thrombosis and Haemostasis, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Fibrin D-Dimer and Coronary Heart DiseaseCirculation, 2001
- C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Minimum effective intensity of oral anticoagulant therapy in primary prevention of coronary heart disease.Archives of internal medicine (1960), 2000
- Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased riskThe Lancet, 1998
- Correlates of Thrombin Markers in an Elderly Cohort Free of Clinical Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Fibrin d -Dimer and β-Thromboglobulin as Markers of Thrombogenesis and Platelet Activation in Atrial FibrillationCirculation, 1996
- Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.Circulation, 1994